R&D Achievements

(B) Six Analytical procedure have been developed and validated:

1. Carminative Oils in Vitazyme (Fungal Diastase with Carminatives)
2. Analytical method developed and validated for Diastase in oral liquid of Fungal Diastase and Pepsin formulation (Vitazyme P)
3. Analytical method developed and validated for pepsin in oral liquid of Fungal Diastase and Pepsin formulation (Vitazyme P)
4. Development and validation of RP-HPLC method for simultaneous determination of Terbutaline Sulphate, Guaiphenesin and Ambroxol Hydrochloride from an oral liquid formulation
5. Development and validation of RP-HPLC method for the analysis of Aciclovir as raw material and also from tablet formulations
6. Carminative Oils in Vitazyme Drops (Fungal Diastase with Carminatives).

R&D in the Pipeline:

R&D is working in the development of products and breakthroughs in the following areas:

1. Cardiovascular
2. Diabetes
3. Calcium and vitamin deficiencies
4. Antiallergics
5. Anti-inflammatory response
6. Pancreatic insufficiencies
7. Probiotics
8. Therapeutic enzymes
9. PCR kit based identification of enteropathogenic microorganisms